Member Exclusive News

The week in industry: First adalimumab biosimilars launched in Europe

This week: AstraZeneca and MSD’s Lynparza granted fourth Orphan Drug Designation and Novartis to acquire US-based biopharma, Endocyte.

Go to the profile of RxNet
Oct 18, 2018

Please sign in or register for FREE

No comments yet.